3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) - 5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections

Details for Australian Patent Application No. 2005247671 (hide)

Owner AstraZeneca AB

Inventors Carcanague, Daniel Robert; Gravestock, Michael Barry

Agent Davies Collison Cave

Pub. Number AU-A-2005247671

PCT Pub. Number WO2005/116024

Priority 0411595.2 25.05.04 GB; 0500056.7 05.01.05 GB

Filing date 24 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4439 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/116024 Priority application(s): WO2005/116024

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247679-Self heating or cooling container

2005247670-3- {4- (pyridin-3-yl) phenyl} -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents